Publicacións en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (17)

2022

  1. Aging-related ILK levels are associated with calcified aortic valve and circulating miR 199-3p levels

    Revista Espanola de Cardiologia, Vol. 75, Núm. 1, pp. 88-91

  2. Challenges in managing patients with heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7

  3. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  4. Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29

  5. Vericiguat: VICTORIA trial results

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22

2021

  1. Ivabradine induces cardiac protection by preventing cardiogenic shock-induced extracellular matrix degradation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1063-1072

  2. Latest developments in 3D echocardiography. A novel tissue transparency tool

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 708

  3. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. A genetic risk score predicts recurrent events after myocardial infarction in young adults

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 623-631

  3. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

  4. Easy and self-administered questionnaire for frailty assessment in a community heart failure unit

    REC: CardioClinics, Vol. 55, Núm. 4, pp. 252-254

  5. Heart Failure in the Time of COVID-19

    Cardiology (Switzerland), Vol. 145, Núm. 8, pp. 481-484

  6. Myocardial injury determination improves risk stratification and predicts mortality in covid-19 patients

    Cardiology Journal, Vol. 27, Núm. 5, pp. 489-496

  7. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 985-993

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Contemporary differences between men and women with acute coronary syndromes: CIAM multicenter registry

    Journal of Cardiovascular Medicine, Vol. 20, Núm. 8, pp. 525-530